PMID- 30620642 OWN - NLM STAT- MEDLINE DCOM- 20190813 LR - 20221207 IS - 1557-8593 (Electronic) IS - 1520-9156 (Linking) VI - 21 IP - 1 DP - 2019 Jan TI - Use of Continuous Glucose Monitoring Trends to Facilitate Exercise in Children with Type 1 Diabetes. PG - 51-55 LID - 10.1089/dia.2018.0292 [doi] AB - Diabetes care during exercise frequently requires interruptions to activity and adds extra challenges particularly for young individuals with type 1 diabetes (T1D). This study investigated the use of a carbohydrate (CHO) intake algorithm based on continuous glucose monitoring (CGM) trends during physical activity. Children with T1D diagnosed for >1 year, ages 8-12 years, with a glycated hemoglobin of <10% were recruited into a randomized crossover study. They attended two similar mornings of fun-based physical activity and adhered to either a CHO intake algorithm based on CGM trends (intervention) or to standard exercise guidelines (consumption of 0.5 g CHO/kg/h when glucose <8 mmol/L) (control). Outcome measures included events such as exercise interruptions, CHO intake, and hypoglycemia events and percentage time spent in different sensor glucose ranges. Fourteen children completed the study. No episodes of significant hypoglycemia (sensor glucose level <3.0 mmol/L) occurred in either arm. Mean CHO intake was the same in both arms, 0.3 +/- 0.2 g/kg/h. However, the intervention algorithm resulted in fewer CHO intake events per day: rate [95% confidence interval] 2.4 [1.6-2.3] versus 0.9 [0.4-1.5], P < 0.001, and exercise interruptions: 7.2 [5.9-8.8] versus 1.4 [0.8-2.1], P < 0.001, compared with control. There was no evidence of a difference in percentage time in range (3.9-10 mmol/L) and percentage time spent high between study arms. Both control and intervention protocols prevented significant hypoglycemia. Using a CHO intake algorithm based on CGM trends resulted in fewer CHO intake events and fewer interruptions to exercise. Use of this algorithm may reduce the burden of diabetes management with potential to facilitate activity in young people with T1D. FAU - Burckhardt, Marie-Anne AU - Burckhardt MA AD - 1 Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Australia. AD - 2 Department of Endocrinology and Diabetes, Perth Children's Hospital, Perth, Western Australia. AD - 3 Division of Paediatrics, within the Medical School, The University of Western Australia, Perth, Australia. FAU - Chetty, Tarini AU - Chetty T AD - 1 Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Australia. AD - 2 Department of Endocrinology and Diabetes, Perth Children's Hospital, Perth, Western Australia. FAU - Smith, Grant J AU - Smith GJ AD - 1 Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Australia. FAU - Adolfsson, Peter AU - Adolfsson P AD - 4 Department of Paediatrics, The hospital of Halland, Kungsbacka, Sweden. AD - 5 Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. FAU - de Bock, Martin AU - de Bock M AD - 1 Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Australia. AD - 2 Department of Endocrinology and Diabetes, Perth Children's Hospital, Perth, Western Australia. FAU - Jones, Timothy W AU - Jones TW AD - 1 Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Australia. AD - 2 Department of Endocrinology and Diabetes, Perth Children's Hospital, Perth, Western Australia. AD - 3 Division of Paediatrics, within the Medical School, The University of Western Australia, Perth, Australia. FAU - Davis, Elizabeth A AU - Davis EA AD - 1 Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Australia. AD - 2 Department of Endocrinology and Diabetes, Perth Children's Hospital, Perth, Western Australia. AD - 3 Division of Paediatrics, within the Medical School, The University of Western Australia, Perth, Australia. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - United States TA - Diabetes Technol Ther JT - Diabetes technology & therapeutics JID - 100889084 RN - 0 (Blood Glucose) RN - 0 (Carbohydrates) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) RN - 0 (hemoglobin A1c protein, human) MH - *Algorithms MH - Blood Glucose/analysis MH - Blood Glucose Self-Monitoring/*methods MH - Carbohydrates/*analysis MH - Child MH - Cross-Over Studies MH - Diabetes Mellitus, Type 1/blood/*drug therapy/physiopathology MH - Exercise/*physiology MH - Female MH - Glycated Hemoglobin MH - Humans MH - Hypoglycemia/chemically induced/prevention & control MH - Hypoglycemic Agents/administration & dosage MH - Male OTO - NOTNLM OT - Carbohydrate intake algorithm. OT - Continuous glucose monitoring OT - Exercise OT - Type 1 diabetes EDAT- 2019/01/09 06:00 MHDA- 2019/08/14 06:00 CRDT- 2019/01/09 06:00 PHST- 2019/01/09 06:00 [entrez] PHST- 2019/01/09 06:00 [pubmed] PHST- 2019/08/14 06:00 [medline] AID - 10.1089/dia.2018.0292 [doi] PST - ppublish SO - Diabetes Technol Ther. 2019 Jan;21(1):51-55. doi: 10.1089/dia.2018.0292.